BONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends September 30
Bon Natural Life Ltd
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 23, 2026
$1.12−0.02 (-1.51%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2019 to 2025
Gross margin
20.8%−7.8 pts over 5 years
Operating margin
-8.7%−27.7 pts over 5 years
Net margin
-10.7%−27.3 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -21.7% | -14.5% | +0.5% | – | |
| Gross profit | -45.4% | -25.6% | -5.7% | – | |
| Free cash flow | – | – | -44.8% | – |
Returns and balance sheet
7 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2019 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | – | -3.9% | |
| Return on assets | – | – | -2.7% | |
| Current ratio | – | 0.93 | 1.74 | |
| Debt to equity | – | 0.48 | 0.21 | |
| Net debt to EBITDA | – | 1.34× | -15.70× | |
| Interest coverage | 9.5× | 10.5× | -4.4× | |
| Inventory turnover | – | – | 6.1× | |
| Capex to revenue | 1.3% | 0.2% | 0.0% | |
| Diluted shares | 5M | 5M | 3M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Bon Natural Life generated $12.72M from operations and spent $155.35K on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$12.72M
Used
$155.35K
Capital expenditure$155.35K100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-10.7%
×Asset turnover0.25×
×Equity multiplier1.45×
=Return on equity, FY2025-3.9%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -10.7% | 0.25× | 1.45× | -3.9% |
| FY2024 | 1.7% | 0.44× | 1.36× | 1.0% |
| FY2023 | 15.6% | 0.70× | 1.29× | 14.1% |
| FY2022 | 20.9% | 0.81× | 1.33× | 22.4% |
| FY2021 | 18.0% | 0.83× | 1.69× | 25.1% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
3of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero-$1.99M
- Cash generatingOperating cash flow above zero$141.12K
- Return on assets improvedROA up on the prior year0.9% → -3.2%
- Earnings backed by cashOperating cash flow above net income$141.12K vs -$1.99M
- Less leverageLong-term debt to assets fell1.6% → 1.0%
- Better liquidityCurrent ratio rose2.42 → 1.74
- No dilutionShare count did not rise0M → 3M
- Gross margin improvedGross margin up on the prior year29.82% → 20.77%
- More efficientAsset turnover rose0.51 → 0.30